8 clinical signs associated with impending death in patients with cancer identified
the ONA take:
According to a new study published in the journal Cancer, researchers at The University of Texas MD Anderson Cancer Center in Houston, Texas, have identified eight highly specific cognitive and physical signs associated with impending death in patients with cancer.
For the prospective study, researchers identified 357 patients with cancer admitted to palliative care units at MD Anderson Cancer Center and Barretos Cancer Hospital in Brazil. Of those patients, 57% died.
The team observed 52 cognitive and physical signs twice daily from the time of admission to discharge or death. Of those, researchers were able to identify eight signs that were most highly associated with impending death within 3 days of presentation.
Those signs include: decreased response to verbal stimuli, inability to close eyelids, nonreactive pupils, decreased response to visual stimuli, neck hyperextension, upper gastrointestinal bleeding, drooping of the nasolabial fold, and grunting of vocal cords.
The researchers note that although this information will not alter clinical practice, it may be helpful knowing that death is imminent so that caregivers can plan appropriately.
The authors also stress that these findings should only be applied to patients with cancer and not to other causes of death.
Researchers identified eight highly specific cognitive and physical signs associated with impending death in patients with cancer.
- Blood Test Predicts Stem Cell Transplant Success in Myelodysplastic Syndrome
- Immunotherapy and the Future of Prostate Cancer Treatment
- Trends in Behaviors, Medical Practice Indicate Mortality From Melanoma Will Decline
- Pembrolizumab Active Against Rare Melanoma, Extends Survival in Bladder Cancer
- Elderly with NSCLC Can Tolerate Aggressive Radiation Therapy Treatments
- Survivors Reporting Chronic Neuropathic Pain Struggle to Retain Jobs
- Lung Cancer Screening Rates Low Among Present and Former Smokers
- Timing of Chemotherapy Infusion Affects Inflammatory Response to Chemotherapy
- Postoperative Gemcitabine Plus Capecitabine: A New Standard of Care for Pancreatic Cancer
- Blood-Forming Stem Cell Transplants (Fact Sheet)
- Pediatric Hepatocellular Carcinoma: Challenges and Solutions
- Earlier and Later Adult BMI Associated With Multiple Myeloma Risk
- Cost-Effectiveness of Immunotherapy for Advanced Melanoma Evaluated
- VBPWPs Can Compliment Patient Management in Clinical Trials
- Communication Technology Improves Treatment Burden, Patient Perspective of Oncology Care
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|